Prescription Required
Inclusive of all taxes
In Glaucoma Brinzagan Opthalmic Suspension belongs to a group of medicines called carbonic anhydrase inhibitors. It is used to reduce pressure in your eyes. This pressure can lead to an illness called glaucoma. If the pressure in your eye is too high, it can damage your sight. You should only use it in the affected eye and take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled. This could lead to a loss of sight. In Ocular hypertension Brinzagan Opthalmic Suspension belongs to a group of medicines called carbonic anhydrase inhibitors. It is used to reduce pressure in your eyes. If the pressure in your eye is too high, it can damage your sight. You should only use it in the affected eye and take it regularly as prescribed by your doctor. If you stop taking it, the pressure in your eye will not be controlled. This could lead to a loss of sight.
No interaction found/established
Brinzagan Opthalmic Suspension may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Brinzagan Opthalmic Suspension is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Brinzagan Opthalmic Suspension may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
No interaction found/established
No interaction found/established
If you miss a dose of Brinzagan Opthalmic Suspension, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Alcon Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ajanta Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sunways India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ajanta Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)